Coronary endothelial function testing provides superior discrimination compared with standard clinical risk scoring in prediction of cardiovascular events

Coronary Artery Disease

Volumn 27, Issue 3, 2016, Pages 213-220

  Reriani, Martin ^a   Sara, Jaskanwal D ^a   Flammer, Andreas J ^a   Gulati, Rajiv ^a   Li, Jing ^a   Rihal, Charanjit ^a   Lennon, Ryan ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

Cardiovascular events; Endothelial dysfunction; Endothelium; Myocardial infarction; Prognosis

Indexed keywords

ACETYLCHOLINE;

ADULT; ARTICLE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ENDOTHELIAL FUNCTION; DIABETES MELLITUS; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REPEAT PROCEDURE; THORAX PAIN; AGED; COMPARATIVE STUDY; COMPLICATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DISEASE COURSE; DISEASE FREE SURVIVAL; DOPPLER ECHOCARDIOGRAPHY; EARLY DIAGNOSIS; HEART FUNCTION TEST; INTRAARTERIAL DRUG ADMINISTRATION; KAPLAN MEIER METHOD; MICROCIRCULATION; MIDDLE AGED; MINNESOTA; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADULT; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, DOPPLER; ENDOTHELIUM, VASCULAR; FEMALE; HEART FUNCTION TESTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; KAPLAN-MEIER ESTIMATE; MALE; MICROCIRCULATION; MIDDLE AGED; MINNESOTA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84958292374     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000347     Document Type: Article

References (40)

1. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non- ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61:e179-e347.
2. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117:743-753.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
4. Reriani MK, Lerman LO, Lerman A. Endothelial function as a functional expression of cardiovascular risk factors. Biomark Med 2010; 4:351-360.
5. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106:653-658.
6. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005; 111:363-368.
7. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101:948-954.
8. Targonski PV, Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Lerman A. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 2003; 107:2805-2809.
9. Matsuzawa Y, Lerman A. Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coron Artery Dis 2014; 25:713-724.
10. Osto E, Coppolino G, Volpe M, Cosentino F. Restoring the dysfunctional endothelium. Curr Pharm Des 2007; 13:1053-1068.
11. Reriani M, Raichlin E, Prasad A, Mathew V, Pumper GM, Nelson RE, et al. Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation 2010; 122:958-966.
12. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997; 96:3390-3395.
13. Reriani M, Raichlin E, Prasad A, Mathew V, Pumper GM, Nelson RE, et al. Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation 2010; 122:958-966.
14. Yoon MH, Reriani M, Mario G, Rihal C, Gulati R, Lennon R, et al. Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis. Int J Cardiol 2013; 168:1316-1321.
15. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension 1991; 18:565-574.
16. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995; 92:2426-2431.
17. Harrison DG, Bates JN. The nitrovasodilators. New ideas about old drugs. Circulation 1993; 87:1461-1467.
18. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992; 85:1899-1911.
19. Ofili EO, Labovitz AJ, Kern MJ. Coronary flow velocity dynamics in normal and diseased arteries. Am J Cardiol 1993; 71:3D-9D.
20. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172. discussion 207-212.
21. Chambless LE, Cummiskey CP, Cui G. Several methods to assess improvement in risk prediction models: extension to survival analysis. Stat Med 2011; 30:22-38.
22. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30:11-21.
23. Reriani MK, Lerman LO, Lerman A. Endothelial function as a functional expression of cardiovascular risk factors. Biomark Med 2010; 4:351-360.
24. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, Ebrahim S. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327:1267.
25. Wong J, Wong V, Fahey T, Brindle P, Hay A. Predictors of postmenopausal osteoporosis: study methods and analysis require clarification. BMJ 2003; 327:392-393.
26. Menotti A, Keys A, Aravanis C, Blackburn H, Dontas A, Fidanza F, et al. Seven Countries Study. First 20-year mortality data in 12 cohorts of six countries. Ann Med 1989; 21:175-179.
27. Araujo AB, Hall SA, Ganz P, Chiu GR, Rosen RC, Kupelian V, et al. Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score? J Am Coll Cardiol 2010; 55:350-356.
28. Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 2012; 308:788-795.
29. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation 2010; 122:2748-2764.
30. 2012 Writing Committee Members, Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-STelevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012; 60:645-681.
31. Qian J, Ge J, Baumgart D, Oldenburg O, Haude M, Sack S, Erbel R. Safety of intracoronary Doppler flow measurement. Am Heart J 2000; 140:502-510.
32. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, et al. Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23:7-17.
33. Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y, Fujioka D, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 2009; 53:323-330.
34. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002; 40:505-510.
35. Fichtlscherer S, Breuer S, Zeiher AM. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the 'vulnerable' patient. Circulation 2004; 110:1926-1932.
36. von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, Sharaf BL, et al. National Heart, Lung, and Blood Institute. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute- Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109:722-725.
37. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999; 34:631-638.
38. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12:56-62.
39. Glaser R, Selzer F, Faxon DP, Laskey WK, Cohen HA, Slater J, et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 2005; 111:143-149.
40. Lavi S, Bae JH, Rihal CS, Prasad A, Barsness GW, Lennon RJ, et al. Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques. Heart 2009; 95: 1525-1530.